CGH
AMED

Crossmark Global Holdings’s Amedisys AMED Stock Holding History

Crossmark Global Holdings’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,466
Closed -$243K – 1290
2025
Q2 		$243K Buy
2,466
+58
+2% +$5.49K ﹤0.01% 1190
2025
Q1 		$223K Sell
2,408
-27
-1% -$2.49K ﹤0.01% 1219
2024
Q4 		$222K Sell
2,435
-79
-3% -$7.25K ﹤0.01% 1168
2024
Q3 		$243K Buy
+2,514
New +$245K ﹤0.01% 1163
2024
Q2 		– Sell
-2,427
Closed -$223K – 1296
2024
Q1 		$223K Sell
2,427
-99
-4% -$9.28K ﹤0.01% 1237
2023
Q4 		$240K Buy
2,526
+28
+1% +$2.62K 0.01% 1180
2023
Q3 		$231K Sell
2,498
-9
-0.4% -$832 0.01% 1143
2023
Q2 		$227K Sell
2,507
-355
-12% -$29.1K ﹤0.01% 1198
2023
Q1 		$210K Buy
2,862
+373
+15% +$32.3K ﹤0.01% 1206
2022
Q4 		$208K Sell
2,489
-264
-10% -$23.8K 0.01% 1186
2022
Q3 		$266K Buy
2,753
+24
+0.9% +$2.86K 0.01% 1044
2022
Q2 		$287K Sell
2,729
-60
-2% -$7.67K 0.01% 1047
2022
Q1 		$480K Sell
2,789
-130
-4% -$19.4K 0.01% 916
2021
Q4 		$473K Sell
2,919
-1,010
-26% -$162K 0.01% 915
2021
Q3 		$586K Sell
3,929
-140
-3% -$29.1K 0.01% 845
2021
Q2 		$997K Sell
4,069
-280
-6% -$73.5K 0.02% 612
2021
Q1 		$1.15M Buy
4,349
+100
+2% +$28.2K 0.03% 547
2020
Q4 		$1.25M Buy
4,249
+550
+15% +$141K 0.03% 508
2020
Q3 		$875K Sell
3,699
-40
-1% -$9.09K 0.02% 577
2020
Q2 		$742K Buy
3,739
+420
+13% +$78.3K 0.02% 624
2020
Q1 		$609K Sell
3,319
-110
-3% -$19.6K 0.02% 595
2019
Q4 		$572K Sell
3,429
-1,640
-32% -$244K 0.02% 738
2019
Q3 		$664K Sell
5,069
-20
-0.4% -$2.6K 0.02% 673
2019
Q2 		$618K Sell
5,089
-520
-9% -$61.7K 0.02% 722
2019
Q1 		$691K Buy
5,609
+10
+0.2% +$1.25K 0.02% 664
2018
Q4 		$656K Sell
5,599
-3,490
-38% -$411K 0.02% 650
2018
Q3 		$1.14M Sell
9,089
-440
-5% -$48.6K 0.03% 554
2018
Q2 		$814K Buy
9,529
+400
+4% +$29.4K 0.02% 691
2018
Q1 		$551K Sell
9,129
-800
-8% -$45.6K 0.01% 856
2017
Q4 		$523K Buy
9,929
+3,830
+63% +$202K 0.01% 962
2017
Q3 		$341K Buy
+6,099
New +$323K 0.01% 1227
2016
Q3 		$341K Buy
+6,099
New +$304K 0.01% 1227

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Crossmark Global Holdings's AMED Position: Q3 2025 in Review

Crossmark Global Holdings sold out of Amedisys (AMED) in Q3 2025, closing a stake of 2,466 shares — an estimated $243K sold.

Crossmark Global Holdings first reported a position in AMED in Q3 2016 and held it in 32 quarters. The position peaked at $1.25M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Crossmark Global Holdings reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Crossmark Global Holdings sold 2,466 Amedisys shares in Q3 2025, an estimated $243K.
  • Crossmark Global Holdings first reported a position in Amedisys in Q3 2016 and held it in 32 quarters.
  • Crossmark Global Holdings's Amedisys position peaked at $1.25M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Crossmark Global Holdings's 13F filing for Q3 2025, filed 12 Nov 2025.